AlphaFold predicted structure
IGBP1 · P78318

Mean pLDDT
81.8/ 100
Confident
339 residues
Confidence breakdown
- Very high(≥ 90)50%
- Confident(70–90)27%
- Low(50–70)15%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
immunoglobulin binding protein 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Ocular coloboma
Structural eye disease
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesDDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesIntellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalescorpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome
Agenesis of the corpus callosum - intellectual disability - coloboma - micrognathia
neurodegenerative disease
nasopharyngeal carcinoma
breast cancer
lobular neoplasia
esophageal squamous cell carcinoma
systemic lupus erythematosus
lung adenocarcinoma
nephritis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Immunoglobulin-binding protein 1
Associated to surface IgM-receptor; may be involved in signal transduction. Involved in regulation of the catalytic activity of the phosphatases PP2A, PP4 and PP6 by protecting their partially folded catalytic subunits from degradative polyubiquitination until they associate with regulatory subunits
IGBP1 · P78318

Mean pLDDT
81.8/ 100
Confident
339 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0